- Home
- MNTK vs LENZ Comparison
MNTK vs LENZ Comparison
Compare MNTK & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNTK | LENZ |
|---|---|---|
| Founded | 1980 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Medicinal Chemicals and Botanical Products |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.0M | 219.8M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MNTK | LENZ |
|---|---|---|
| Price | $1.62 | $6.50 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $1.80 | ★ $44.00 |
| AVG Volume (30 Days) | 189.1K | ★ 654.4K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $176,382,000.00 | $19,088,000.00 |
| Revenue This Year | $18.55 | $50.42 |
| Revenue Next Year | $12.68 | $197.16 |
| P/E Ratio | $146.00 | ★ N/A |
| Revenue Growth | ★ 0.37 | N/A |
| 52 Week Low | $1.07 | $6.52 |
| 52 Week High | $2.78 | $50.19 |
Technical Indicators
Market Signals| Indicator | MNTK | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 50.94 | 32.79 |
| Support Level | $1.59 | N/A |
| Resistance Level | $1.78 | $10.42 |
| Average True Range (ATR) | 0.10 | 0.44 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 29.84 | 7.94 |
Price Performance
Historical ComparisonAbout MNTK Montauk Renewables Inc.
Montauk Renewables Inc is a renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments namely Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.